Case Report: Nystagmus as a core presenting sign in pediatric anti-Ma2 antibody-associated cerebellar ataxia: diagnostic implications from clinical and serological profiling
Nystagmus was first identified in pediatric patients with anti-Ma2 antibody-associated syndrome, expanding clinicians' knowledge of the phenotype in children. Our case demonstrates that IVIG and steroids induced rapid and sustained remission despite presumed cell-mediated immunity cases, with complete symptom resolution within 8 weeks and no recurrence at 1-year follow-up. We also emphasize CBA's superior accessibility and its higher sensitivity and specificity in detecting low-titer antibodies for detecting antibodies in autoimmune encephalitis, particularly in mild or atypical presentations.
Authors
- Zhijian Li (ORCID: https://orcid.org/0000-0002-7364-6131)
- Kaliadin Ni (ORCID: https://orcid.org/0009-0006-0170-7640)
- Jiehui Ma
- Ping Cao (ORCID: https://orcid.org/0000-0002-3049-7084)
- Xiaofang Cai (ORCID: https://orcid.org/0009-0000-7041-0927)
- Dan Sun (ORCID: https://orcid.org/0009-0000-8905-3907)
- Yuting Yang (ORCID: https://orcid.org/0000-0001-6897-3130)
- Qianqian Tan
Institutions
- Wuhan Municipal Engineering Design & Research Institute (CN)
- Wuhan Children's Hospital (CN)
- Wuhan YZY Biopharma (China) (CN)
- Huazhong University of Science and Technology (CN)
Publication Details
- Journal
- Frontiers in Pediatrics
- Published
- 2025-10-15
- DOI
- https://doi.org/10.3389/fped.2025.1659483
- Primary Topic
- Autoimmune Neurological Disorders and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00